ERcast: Clinical Perspectives Podcast Preview

COVID Vaccine Safety in Pregnancy

COVID Vaccine Safety in Pregnancy

  • Apr 2021
  • 1 Chapter
  • 10 min

In this Hippo Education bonus, Dr. Rob Orman digs into the data just published regarding mRNA vaccine safety in pregnant patients, and what it means for our patients. He also reviews data just published looking at the effect of COVID on maternal and neonatal morbidity and mortality among pregnant women.

Faculty

  • Rob Orman, MD

    Dr. Rob Orman is an emergency physician, educator, and executive coach specializing in physician performance and professional fulfillment. After more than 20 years in community emergency medicine, he now works with clinicians across specialties to address burnout, inefficiency, and career challenges. He earned his medical degree from Emory University School of Medicine and completed his residency at Denver Health Medical Center, where he served as chief resident. Dr. Orman is the founder of the Stimulus podcast and Orman Physician Coaching. He previously served as chief editor of ERcast and hosted Essentials of Emergency Medicine for nearly a decade.

Chapters

HIPPO COVID Infection and Vaccine Safety in Pregnancy

COVID-19 in pregnancy increases maternal and neonatal risk, while mRNA vaccine safety data in pregnant patients remain reassuring. The key questions are severe maternal outcomes, preterm birth, stillbirth, and whether vaccination signals miscarriage, congenital anomalies, or other major obstetric harm. COVID Risks and Vaccine Safety Maternal disease severity: Pregnancy is a high-risk state for severe COVID-19, with higher rates of ICU-level illness, ventilation, and maternal morbidity than in nonpregnant peers. Neonatal outcome burden: Maternal infection tracks with worse neonatal outcomes, especially preterm birth and downstream NICU utilization, a distinction we put into practical counseling language in the episode. mRNA vaccine reassurance: Large observational pregnancy datasets have not shown a major safety signal for mRNA vaccines, including miscarriage and congenital anomaly concerns. Risk-benefit counseling frame: The clean bedside message is that infection risk is measurable and consequential, while vaccine harms have not emerged as a comparable signal in the available data. Patient-centered counseling nuances: Counseling still needs nuance around timing, uncertainty, and individual comorbidity. We get into the phrasing that helps with hesitant patients in the chapter.